1.04

9.46% 0.0899

Cdt Equity Inc (CDT)

Overview News Price History Why CDT Down? Discussions Forecast

Cdt Equity Inc stock is traded at $1.04, with a volume of 45.77M. It is up +9.46% in the last 24 hours and down -53.77% over the past month. CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.

Previous Close:

$0.9501

Open:

$1.1

24h Volume:

45.77M

Relative Volume:

55.61

Market Cap:

$5.05M

Revenue:

Net Income/Loss:

$-39.62M

P/E Ratio:

-0.000629

EPS:

-1654.3275

Net Cash Flow:

$-17.96M

1W Performance:

-0.95%

1M Performance:

-53.77%

6M Performance:

-97.95%

1Y Performance:

-99.86%

1-Day Range:

$0.933

$2.89

1-Week Range:

$0.7932

$2.89

52-Week Range:

$0.7932

$848.00

Cdt Equity Inc Stock (CDT) Company Profile

Name

Cdt Equity Inc

Sector

Healthcare (1108)

Industry

Biotechnology (618)

Phone

(646) 491 9132

Address

4851 TAMIAMI TRAIL NORTH, NAPLES

Employee

Twitter

Next Earnings Date

2026-06-04

Latest SEC Filings

CDT's Discussions on Twitter

Compare CDT vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CDT Cdt Equity Inc	1.04	4.62M	0	-39.62M	-17.96M	-1,654.33
VRTX Vertex Pharmaceuticals Inc	447.54	113.70B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	614.78	65.16B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	835.99	52.14B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	301.98	40.73B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	157.48	32.87B	742.00K	-1.37B	-1.07B	-7.0731

Cdt Equity Inc Stock (CDT) Latest News

May 29, 2026

CDT Equity Inc. Receives Nasdaq Deficiency Letter for Non-Compliance - geneonline.com

May 28, 2026

CDT Equityhas until July 20, 2026 to submit Nasdaq compliance plan - marketscreener.com

May 28, 2026

Nasdaq warns CDT Equity (CDT) over delayed Form 10-Q but trading continues - Stock Titan

May 28, 2026

CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter - marketscreener.com

May 28, 2026

CDTTW Warrants Remain at Floor Level – CDT Equity Inc. (CDTTW) Shows No Price MovementArms Index - thelegaladvocate.com

May 28, 2026

CDT Environmental Technology Investment Holdings Limited Announces Share Consolidation - Yahoo Finance

May 28, 2026

May 27, 2026

CDTTW Warrants Trade Flat at $0.01 Amidst Minimal ActivityEase of Movement - newsline.com

May 27, 2026

CDT Equity receives Canadian patent for male infertility drug - Investing.com

May 27, 2026

CDT Equity receives Canadian patent for male infertility drug By Investing.com - Investing.com South Africa

May 27, 2026

No approved drugs for male infertility — but CDT just secured a key patent - Stock Titan

May 27, 2026

CDT Equity Company Profile & Introduction - Moomoo

May 27, 2026

May 22, 2026